237
Participants
Start Date
December 26, 2013
Primary Completion Date
November 24, 2014
Study Completion Date
May 31, 2017
Secukinumab 300mg
Secukinumab was used as 150 mg pre-filled syringes (PFS) in a double-blinded fashion. Secukinumab 300 mg s.c. (two PFS injections of the 150 mg dose) self-administered
Secukinumab 150mg
secukinumab 150 mg s.c. (one PFS injection of the 150 mg dose + one PFS injection of placebo) self-administered
Placebo
secukinumab placebo s.c. (two PFS injections of placebo) self-administered
Novartis Investigative Site, Vienna
Novartis Investigative Site, Brussels
Novartis Investigative Site, Leuven
Novartis Investigative Site, Liège
Novartis Investigative Site, Graz
Novartis Investigative Site, Ghent
Novartis Investigative Site, Berlin
Novartis Investigative Site, Martigues
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Mahlow
Novartis Investigative Site, Greifswald
Novartis Investigative Site, Schwerin
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Kiel
Novartis Investigative Site, Brescia
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Göttingen
Novartis Investigative Site, San Cristóbal de La Laguna
Novartis Investigative Site, Bologna
Novartis Investigative Site, Bochum
Novartis Investigative Site, Recklinghausen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Münster
Novartis Investigative Site, Clermont-Ferrand
Novartis Investigative Site, Hanau
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Novartis Investigative Site, Rouen
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Poitiers
Novartis Investigative Site, Limoges
Novartis Investigative Site, Moscow
Novartis Investigative Site, Rostov on Don Region
Novartis Investigative Site, Ryazan
Novartis Investigative Site, Saratov
Novartis Investigative Site, Feldkirch
Novartis Investigative Site, Linz
Novartis Investigative Site, Vienna
Novartis Investigative Site, Nice
Novartis Investigative Site, Dresden
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Gera
Novartis Investigative Site, Plauen
Novartis Investigative Site, Bydgoszcz
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Olsztyn
Novartis Investigative Site, Zabrze
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Jönköping
Novartis Investigative Site, Malmo
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Leytonstone
Novartis Investigative Site, Salford
Novartis Investigative Site, Dundee
Novartis Investigative Site, Dudley
Novartis Investigative Site, Glasgow
Novartis Investigative Site, Liverpool
Novartis Investigative Site, Newport
Novartis Investigative Site, Portsmouth
Novartis Investigative Site, Wolverhampton
Novartis Investigative Site, York
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY